Lessons from Covid: Pharma firms turn attention to adult vaccination

Vaccine companies have warmed up to the idea of adult vaccines for other diseases such as pneumonia, flu and shingles as well

Sohini Das | Mumbai
Last Updated at December 5, 2022 00:58 IST

Companies are, in fact, creating new teams as their focus on adult vaccination increases

The Covid-19 pandemic led to the world’s largest adult vaccination campaign, with more than 13 billion doses administered globally, so far. Around 2.5 million doses of Covid-19 vaccines are being administered daily now across the world. Vaccine companies have thus warmed up to the idea of adult vaccination against non-Covid infections, as well — pneumonia, flu, and shingles, to name a few.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

MONTHLY

₹ 249

Select

ANNUAL

₹ 1799

Select

Best Offer

SMART ANNUAL

₹ 1499

₹ 1799

Opt for auto renewal and save Rs 300

Select

What you get on Business Standard Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Pick your 5 favourite companies, get a daily email with all news updates on them.
26 years of website archives.
Preferential invites to Business Standard events.